LogicBio Therapeutics Inc (LOGC)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Frederic Chereau
Employees:
23
99 ERIE STREET, CAMBRIDGE, MA 02139
617-245-0399

LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. Its lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. The company has a partnership with Children's Medical Research Institute to develop new viral vectors. LogicBio Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 98.333 Million Shares Outstanding32.24 Million Avg 30-day Volume 89.945 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.33
Price to Revenue80.9012 Debt to Equity0.1857 EBITDA-31.675 Million
Price to Book Value4.3177 Operating Margin-1112.0939999999998 Enterprise Value180.258 Million
Current Ratio8.585 EPS Growth0.351 Quick Ratio8.313
1 Yr BETA 1.3021 52-week High/Low 9.75 / 2.75 Profit Margin-1155.7706
Operating Cash Flow Growth22.5878 Altman Z-Score4.5937 Free Cash Flow to Firm -22.614 Million
View SEC Filings from LOGC instead.

View recent insider trading info

Funds Holding LOGC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LOGC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GRUSKIN DANIEL CHIEF MEDICAL OFFICER

  • Officer
3,331 2021-08-06 3

KAY MARK A

  • Director
5,000 2021-06-18 3

MOSCICKI RICHARD A

  • Director
12,500 2021-06-11 2

WYZGA MICHAEL S

  • Director
12,500 2021-06-11 2

ENYEDY MARK J

  • Director
12,500 2021-06-11 2

GOATER JEFF

  • Director
12,500 2021-06-11 3

CHEN LEON

  • Director
12,500 2021-06-11 2

KARYDAS DAPHNE

  • Director
12,500 2021-06-11 3

PAUL ANDREA GENERAL COUNSEL AND SECRETARY

  • Officer
165,000 2021-05-17 2

CHEREAU FREDERIC PRESIDENT AND CHIEF EXECUTIVE

  • Officer
  • Director
515,164 2021-04-15 2

CHIANG KYLE CHIEF OPERATING OFFICER

  • Officer
49,751 2021-04-15 2

JONES CECILIA CHIEF FINANCIAL OFFICER

  • Officer
78,000 2021-02-23 3

QUICK JONATHAN SENIOR DIRECTOR-FINANCE

  • Officer
0 2021-01-01 1

O'CONNELL DANIEL P

  • Director
No longer subject to file 2020-12-10 1

NACHT MARIANA CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-11-30 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED ADVISORS ISRAEL II LTD

ORBIMED ISRAEL GP II, L.P.

ORBIMED GENESIS GP LLC

  • Director
  • 10% Owner
7,948,265 2020-10-01 0

CHIMOVITS EREZ

  • Director
  • 10% Owner
7,948,265 2020-10-01 0

ARIX BIOSCIENCE PLC

ARIX BIOSCIENCE HOLDINGS LTD

  • 10% Owner
2,381,436 2020-07-16 0

JAFFE MATTHIAS CHIEF FINANCIAL OFFICER

  • Officer
0 2020-04-15 0

YOON SEOKHO BRYAN CHIEF ADMIN OFFICER & GC

  • Officer
0 2020-04-15 0

HUTTNER KENNETH SVP, HEAD OF CLINICAL DEV.

  • Officer
0 2020-02-11 0

KARIV TOMER

  • Director
0 2019-12-19 0

WILTON THOMAS CHIEF BUSINESS OFFICER

  • Officer
75,000 2019-08-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 22:15:03 UTC -0.9467 1.0167 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 21:45:03 UTC -0.9467 1.0167 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 21:15:04 UTC -0.9467 1.0167 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 20:45:03 UTC -0.9236 0.9936 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 20:15:03 UTC -0.9236 0.9936 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 19:45:03 UTC -0.9236 0.9936 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 19:15:04 UTC -0.9236 0.9936 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 18:45:04 UTC -0.9169 0.9869 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 18:15:03 UTC -0.9169 0.9869 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 17:45:03 UTC -0.9169 0.9869 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 17:15:03 UTC -0.9169 0.9869 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 16:45:03 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 16:15:04 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 15:45:03 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 15:15:03 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 14:45:03 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 14:15:05 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 13:45:03 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 13:15:03 UTC -0.9111 0.9811 650000
LOGICBIO THERAPEUTICS INC LOGC 2021-12-03 12:45:03 UTC -0.9111 0.9811 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments